CARSON CITY, Nev., April 16, 2025 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of ...
Obstructive sleep apnea (OSA) has been linked to a significantly increased risk for Parkinson’s disease (PD). However, early treatment of OSA with continuous positive airway pressure (CPAP) ...
SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results